Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 778 of 1,261

  1. US 8912334

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  2. US 8912323

    Multifunctional small molecules

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  3. CA 2853911

    PROCEDE DE FABRICATION DE MELANGES GAZEUX NO/N2 DESTINES AU DOMAINE MEDICAL

    AIR LIQUIDE SANTE INT [FR] · Granted Dec 12, 2014 · Expires Dec 7, 2034

    granted

  4. US 8906413

    Drug formulations having reduced abuse potential

    Supernus Pharmaceuticals, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  5. US 8907053

    Immunosuppression modulating compounds

    Aurigene Discovery Technologies Limited · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  6. US 8906862

    Multiple antigen delivery system using hepatitis E virus-like particle

    The Regents of the University of California · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  7. US 8906343

    PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  8. US 8905235

    Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom

    Nektar Therapeutics · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  9. US 8907060

    Mutated Pseudomonas exotoxins with reduced antigenicity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  10. US 8906917

    Pyrimidine cyclohexyl glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  11. US 8906872

    Antisense antiviral compound and method for treating ssRNA viral infection

    Sarepta Therapeutics, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  12. US 8905913

    Method and composition for synchronizing time of insemination

    JBS United Animal Health II LLC · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  13. US 8906949

    Orally disintegrating tablets of zolmitriptan and process for preparing the same

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  14. US 8906939

    3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives

    Addex Pharma, S.A. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  15. US 8906922

    Substituted triazoles useful as AXl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  16. US 8906901

    Administration of dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  17. US 8906897

    Antimicrobial agents based on hemin derivatives

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  18. US 8906863

    Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

    The Regents of the University of California · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  19. US 8906853

    [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  20. US 8906668

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Health, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  21. US 8906411

    Pre-compacted calcium-containing compositions

    TAKEDA NYCOMED AS · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  22. US 8906384

    Antiviral activity of bovine type III interferon against foot-and-mouth disease virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  23. US 8906358

    Leishmania challenge model

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  24. US 8906353

    Compositions and methods for achieving sustained therapeutic drug concentrations in a subject

    Nektar Therapeutics · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.